Theravance Biopharma Inc

Latest Theravance Biopharma Inc News and Updates

  • uploads///KGC
    Energy & Utilities

    Baupost Group opens PBF position, raises MU and THRX share, and sells AIG, AUY, and KGC—13F Flash F

    The Baupost Group, LLC, is a hedge fund founded and run by Seth Klarman in 1982. Why sell Kinross Gold Corp. (KGC)?

    By Samantha Nielson
  • uploads///Iridian_Position Changes_
    Fund Managers

    Highlights of Iridian Asset Management’s holdings: 13G filing

    In its recent 13G filing, Iridian Asset Management disclosed the sale of two of its major holdings and amendments to 14 of its prevailing positions.

    By Stuart McKenzie
  • uploads///AIG
    Energy & Utilities

    Baupost Group opens PBF position, raises MU and THRX share, and sells AIG, AUY, and KGC—13F Flash D

    The Baupost Group, LLC, is a hedge fund founded and run by Seth Klarman in 1982. Why sell American International Group (AIG)?

    By Samantha Nielson
  • uploads///AUY
    Energy & Utilities

    Baupost Group opens PBF position, raises MU and THRX share, and sells AIG, AUY, and KGC—13F Flash E

    The Baupost Group, LLC, is a hedge fund founded and run by Seth Klarman in 1982. Why sell Yamana Gold Inc. (AUY)?

    By Samantha Nielson
  • uploads///EBAY
    Consumer

    Why the Baupost Group adds new position in eBay

    The Baupost Group added a stake in eBay Inc. (EBAY) that accounted for 3.62% of the fund’s total second quarter portfolio. eBay is a global technology company that enables commerce through three reportable segments—Marketplaces, Payments, and Enterprise.

    By Samantha Nielson
  • uploads///Noxafil and Cubicin
    Company & Industry Overviews

    Understanding the Performance of Merck’s Hospital Acute Care Drugs Noxafil and Cubicin

    In 4Q17, Merck’s (MRK) Cubicin reported revenues of $92 million, which was ~23% lower on a YoY (year-over-year) basis.

    By Daniel Collins
  • uploads///TBPH
    Consumer

    Why the Baupost Group starts new position in Theravance Biopharma

    The Baupost Group added a position in Theravance Biopharma Inc. (TBPH) that accounted for 9.89% of the fund’s total second quarter portfolio. Theravance Biopharma was recently spun out of Theravance (THRX).

    By Samantha Nielson
  • Consumer

    Must-know: The Baupost Group’s 2Q14 positions

    The size of the fund’s U.S. long portfolio increased 48% to $6.14 billion in the second quarter from $4.14 billion in the first quarter. The fund’s top positions include Micron Technology, Idenix Pharmaceuticals, and Viasat.

    By Samantha Nielson
  • uploads///HALO_Portfolio
    Fund Managers

    Halozyme Therapeutics gets huge 60% increase in Iridian holdings

    Iridian Asset Management now holds 11,625,215 shares of Halozyme Therapeutics Inc. (HALO), a huge 60% increase. The fund has a 9% stake in the company.

    By Stuart McKenzie
  • uploads///SCI_Stewart Synergies
    Fund Managers

    Service Corporation International gets slight increase in Iridian

    Iridian currently has 10,484,630 shares of Service Corporation International, which is a small increase. Iridian has 5% passive stake in the company.

    By Stuart McKenzie
  • uploads///Menu
    Company & Industry Overviews

    Why Texas Roadhouse Increased Its Menu Prices

    The company increased its menu prices by 1.5% in early December of 2013, and in 2012, it increased menu prices by 2.2%.

    By Adam Jones
  • uploads///SEMI
    Consumer

    The Baupost Group opens new position in SunEdison Semiconductor

    The Baupost Group added a position in SunEdison Semiconductor (SEMI) that accounted for 1.14% of the fund’s total second quarter portfolio. SunEdison Semiconductor develops, manufactures, and sells silicon wafers to the semiconductor industry.

    By Samantha Nielson
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.